Traditional Chinese medicine (TCM) remains a valuable source for drug discovery. From 1999 to 2021, over 3,000 clinical ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, ...

University of Melbourne researchers have developed a revolutionary 3D bioprinting technology that could transform medical ...

Biomedical engineers have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissue to harder ...

A survey of a waterway on Wurundjeri land has led to the discovery of new viruses that kill the superbug Klebsiella.

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, ...

While AI is making significant strides in healthcare, it is also transforming other industries, such as insurance.

Medera Inc. ("Medera"), a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches, ...

The platform helps enable drug discovery teams to achieve high precision target ... “In our discussions with biopharma companies, the desire for AI transformation of their traditional R&D processes is ...

In addition to improving print speed, dynamic interface printing enables a degree of cell positioning within printed tissues.